Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Koko Asakura"'
Autor:
Shuhei Okazaki, Haruko Yamamoto, Koko Asakura, Katsuhiro Omae, Hirotada Maeda, Kanta Tanaka, Shiro Yamamoto, Teruyuki Hirano, Yasuyuki Iguchi, Manabu Sakaguchi, Masatoshi Koga, Masafumi Ihara, Kazunori Toyoda, Teruo Noguchi, Nobuyuki Sakai, Hiroshi Yamagami
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundThe addition of antiplatelet therapy to anticoagulant therapy in patients with stroke with non-valvular atrial fibrillation (NVAF) and atherothrombotic disease may increase bleeding risk without reducing recurrent stroke risk.AimsTo evaluat
Externí odkaz:
https://doaj.org/article/b71ef3d47ce74394a13ac00d5b4287d0
Autor:
Yohei Miyashita, Tatsuro Hitsumoto, Hiroki Fukuda, Jiyoong Kim, Shin Ito, Naoki Kimoto, Koko Asakura, Yutaka Yata, Masami Yabumoto, Takashi Washio, Masafumi Kitakaze
Publikováno v:
EClinicalMedicine, Vol 67, Iss , Pp 102353- (2024)
Summary: Background: Although previous studies have showed that metabolic syndrome is one of the contributors of pancreatic cancer, there is no clear consensus that early stages of metabolic syndrome are linked to increased incidence of pancreatic ca
Externí odkaz:
https://doaj.org/article/94c57e55a12f47ddbd50c93b5c150b63
Autor:
Kohei Ishibashi, Yoshinobu Eishi, Nobuhiro Tahara, Masanori Asakura, Naka Sakamoto, Kazufumi Nakamura, Yoichi Takaya, Tomohisa Nakamura, Yoshikazu Yazaki, Tetsuo Yamaguchi, Koko Asakura, Toshihisa Anzai, Teruo Noguchi, Satoshi Yasuda, Fumio Terasaki, Toshimitsu Hamasaki, Kengo Kusano
Publikováno v:
Journal of Arrhythmia, Vol 34, Iss 5, Pp 520-526 (2018)
Abstract Background Cardiac sarcoidosis (CS) is a noncaseating granulomatous disease of unknown etiology. Lifelong immunosuppressive therapy, most frequently using corticosteroids, is a standard therapy to control hypersensitivity of immune reactions
Externí odkaz:
https://doaj.org/article/e1b4936c82794af1ad893e1b730fb07f
Autor:
Masatoshi Koga, Manabu Inoue, Kaori Miwa, Sohei Yoshimura, Mayumi Fukuda-Doi, Junya Aoki, Koko Asakura, Takao Kanzawa, Masafumi Ohtaki, Kenji Kamiyama, Yusuke Yakushiji, Shuichi Igarashi, Ryosuke Doijiri, Yasuhiro Ito, Yasushi Takagi, Makoto Sasaki, Takanari Kitazono, Kazumi Kimura, Kazuo Minematsu, Haruko Yamamoto, Kazunori Toyoda
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 30:15-22
This study aimed to assess the potential effect of prior antithrombotic medication for thrombolysis in an unknown onset stroke.This was a predefined sub-analysis of the THAWS trial. Stroke patients with a time last known well >4.5 h who had a DWI-f
Autor:
Keiko Shimamoto, Seiko Ohno, Koichi Kato, Koichiro Takayama, Keiko Sonoda, Megumi Fukuyama, Takeru Makiyama, Satomi Okamura, Koko Asakura, Noriaki Imanishi, Yoshiaki Kato, Heima Sakaguchi, Tsukasa Kamakura, Mitsuru Wada, Kenichiro Yamagata, Kohei Ishibashi, Yuko Inoue, Koji Miyamoto, Satoshi Nagase, Kengo Kusano, Minoru Horie, Takeshi Aiba
Publikováno v:
Heart. 108:840-847
ObjectiveHuman cardiacryanodine receptor 2(RYR2) shows autosomal-dominant inheritance in catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1); however,de novovariants have been observed in sporadic cases. Here, we investigated CPVT1-r
Autor:
Teruo Noguchi, Osami Kawarada, Mitsuyo Mizuseki, Sayaka Funabashi, Takeshi Yagyu, Masanori Asakura, Masafumi Kitakaze, Satoshi Yasuda, Kikuko Ohshima, Koko Asakura, Kaori Onda, Shin Ito, Mayumi Fukuda-Doi, Haruko Yamamoto
Publikováno v:
Circulation Reports
Background: Endovascular treatment with balloon angioplasty plays a major role in revascularization of below-the-knee (BTK) arteries in patients with critical limb ischemia (CLI). However, with severely calcified lesions, achieving optimal revascular
Autor:
Kazunori Toyoda, Yusuke Yakushiji, Shuichi Igarashi, Yoshiaki Shiokawa, Toshimitsu Hamasaki, Ryosuke Doijiri, Shinichi Yoshimura, Masafumi Ihara, Hideyuki Ohnishi, Kaori Miwa, Yoshikazu Uesaka, Haruko Yamamoto, Yasushi Takagi, Masato Osaki, Ryo Itabashi, Junya Aoki, Rei Kondo, Taizen Nakase, Takao Urabe, Akira Tsujino, Kazumi Kimura, Takanari Kitazono, Yasuhiro Ito, Takao Kanzawa, Sohei Yoshimura, Shunya Takizawa, Kazuo Minematsu, Takeshi Inoue, Yoshinari Nagakane, Akira Oita, Yasuhiro Hasegawa, Kenji Kamiyama, Masafumi Ohtaki, Toru Iwama, Toshihiro Ueda, Makoto Sasaki, Nobuyuki Sakai, Koko Asakura, Masatoshi Koga, Manabu Inoue, Yasushi Okada, Mayumi Fukuda-Doi
Publikováno v:
Stroke. 51(5):1530-1538
Background and Purpose— We assessed whether lower-dose alteplase at 0.6 mg/kg is efficacious and safe for acute fluid-attenuated inversion recovery-negative stroke with unknown time of onset. Methods— This was an investigator-initiated, multicent
Autor:
Junya Aoki, Taizen Nakase, Shunya Takizawa, Kaori Miwa, Kazumi Kimura, Haruko Yamamoto, Masafumi Ihara, Kazunori Toyoda, Yusuke Yakushiji, Sohei Yoshimura, Koko Asakura, Masatoshi Koga, Mayumi Fukuda-Doi, Manabu Inoue, Yoshinari Nagakane, Yasushi Okada, Makoto Sasaki
Publikováno v:
International journal of stroke : official journal of the International Stroke Society. 17(6)
Background and aim We determined to investigate the incidence and clinical impact of new cerebral microbleeds after intravenous thrombolysis in patients with acute stroke. Methods The THAWS was a multicenter, randomized trial to study the efficacy an
Autor:
Kaori Miwa, Mayumi Fukuda-Doi, Haruko Yamamoto, Masafumi Ihara, Kenji Kamiyama, Shuichi Igarashi, Kazumi Kimura, Kazunori Toyoda, Junya Aoki, Ryosuke Doijiri, Makoto Sasaki, Yasushi Takagi, Takanari Kitazono, Yasuhiro Ito, Kazuo Minematsu, Masatoshi Koga, Manabu Inoue, Sohei Yoshimura, Masafumi Ohtaki, Koko Asakura
Publikováno v:
Stroke. 52
Background and purpose: To assess the potential effect of prior antithrombotic medication for thrombolysis using alteplase at 0.6mg/kg in unknown onset stroke. Methods: This was a prespecified sub-analysis of a THAWS trial (an investigator-initiated,
Autor:
Kazunori Toyoda, Manabu Inoue, Sohei Yoshimura, Hiroshi Yamagami, Makoto Sasaki, Mayumi Fukuda-Doi, Kazumi Kimura, Koko Asakura, Kaori Miwa, Takao Kanzawa, Masafumi Ihara, Rei Kondo, Masayuki Shiozawa, Masafumi Ohtaki, Kenji Kamiyama, Ryo Itabashi, Toru Iwama, Junya Aoki, Kazuo Minematsu, Haruko Yamamoto, Masatoshi Koga, Ban Mihara, Wataru Mouri, Eisuke Furui, Yukako Yazawa, Yukiko Enomoto, Yusuke Egashira, Yusuke Yakushiji, Taizen Nakase, Ryosuke Doijiri, Yasuhiro Ito, Junichiro Suzuki, Yoshinari Nagakane, Eijiro Tanaka, Yasushi Okada, Seiji Gotoh, Shuichi Igarashi, Hideyuki Ohnishi, Hiroyuki Ohnishi, Akira Tsujino, Yohei Tateishi, Shunya Takizawa, Kazunari Homma, Yoshiaki Shiokawa, Rieko Suzuki, Nobuyuki Sakai, Kenichi Todo, Nobuyuki Ohara, Yasuhiro Hasegawa, Naoshi Sasaki, Shuji Arakawa, Masato Osaki, Tsuyoshi Inoue, Yasushi Takagi, Yasuhisa Kanematsu, Shinichi Yoshimura, Yoshikazu Uesaka, Takao Urabe, Masao Watanabe, Toshihiro Ueda, Shoichiro Sato, Toshimitsu Hamasaki, Megimi Sakakibara, Takanari Kitazono, Toshiho Ohtsuki, Wataru Shimizu, Takashi Sozu, Teruyuki Hirano, Kohsuke Kudo, Naomi Morita, Ken Kuwahara, Akira Oita, Kenta Seki, Toshihiro Ide, Takashi Okada, Hajime Ikenouchi, Hiromi Ohara, Mihoko Uotani, Kayo Murata, Shoko Kamiyoshi, Haruka Kanai, Azusa Tokunaga, Ai Ito
Publikováno v:
Stroke. 52(1)
Background and Purpose: We determined to identify patients with unknown onset stroke who could have favorable 90-day outcomes after low-dose thrombolysis from the THAWS (Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes With Alteplase at 0.6 m